Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

MARKSANS PHARMA LTD. - 524404 - Board Meeting Intimation for Notice Of Board Meeting

 MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/06/2020 ,inter alia, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company will be held on Tuesday, 2nd June, 2020 at Mumbai, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended 31st March, 2020. The Board of Directors will also consider recommendation of dividend, if any, for the Financial Year 2019-20. Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company''s shares has been closed for the Company''s insiders from 1st April, 2020 and will remain closed till Forty-Eight hours after the announcement of the Financial Results on 2nd June, 2020.
23-05-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Regulation 40 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 We enclose herewith Certificate issued by S. S. Rauthan & Associates, Company Secretaries for the half year ended 31st March, 2020 as required under Regulation 40(9) & 40 (10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
07-05-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period October 1, 2019 to March 31, 2020 (both days inclusive) by the Company''s Registrar and Share Transfer Agent, viz., M/s. Bigshare Services Pvt. Ltd.
23-04-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Credit Rating

 Intimation of Revision in Credit Ratings of Marksans Pharma Limited by Fitch Group.
23-04-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Shareholding for the Period Ended March 31, 2020

 Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
20-04-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2020 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company.
16-04-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Statement Of Investor Complaints For The Quarter Ended March 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer
16-04-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Redemption Of 200000 7% Redeemable Cumulative Preference Share Of Rs. 100/- Each At Par

 We wish to inform you that the Company has redeemed 200000 7% Redeemable Cumulative Preference Shares of Rs. 100/- each face value (Preference Shares) partly at par today i.e. 31st March, 2020.
31-03-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Re-Appointment Of Mr. Seetharama Raju Buddharaju As An Independent Director For A Further Term Of Five Years With Effect From 1St April, 2020.

 This is to inform you that tenure of Mr. Seetharama Raju Buddharaju (DIN: 03630668) as an Independent Director of the Company comes to end today i.e. 31st March, 2020. The Board of Directors of the Company on the recommendation of the Nomination and Remuneration Committee has re-appointed, subject to approval of the shareholders of the Company at their next General Meeting, Mr. Seetharama Raju Buddharaju (DIN: 03630668) as an Independent Director for a term of five (5) consecutive years with effect from 1st April, 2020 not liable to retire by rotation.
31-03-2020
Bigul

MARKSANS PHARMA LTD. - 524404 - Closure of Trading Window

 Trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company will remain closed with effect from Wednesday, 1st April, 2020 till 48 hours after the declaration of financial results for the quarter and financial year ended 31st March, 2020. The date of declaration of financial results will be intimated separately in due course of time.
30-03-2020
Next Page
Close

Let's Open Free Demat Account